Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus

Chonlatip Pipattanaboon,1,3,8,* Tadahiro Sasaki,2,8,* Mitsuhiro Nishimura,2,8 Chayanee Setthapramote,1,8 Pannamthip Pitaksajjakul,1,4,8 Pornsawan Leaungwutiwong,1,3,8 Kriengsak Limkittikul,5,8 Orapim Puiprom,6 Mikiko Sasayama,6 Panjaporn Chaichana,6 Tamaki Okabayashi,6 Takeshi Kurosu,2,8 Ken-ichiro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pipattanaboon C, Sasaki T, Nishimura M, Setthapramote C, Pitaksajjakul P, Leaungwutiwong P, Limkittikul K, Puiprom O, Sasayama M, Chaichana P, Okabayashi T, Kurosu T, Ono K, Ramasoota P, Ikuta K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f3dd272a402048f694762e6be757b112
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f3dd272a402048f694762e6be757b112
record_format	dspace
spelling	oai:doaj.org-article:f3dd272a402048f694762e6be757b1122021-12-02T02:51:19ZCross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus1177-54751177-5491https://doaj.org/article/f3dd272a402048f694762e6be757b1122013-08-01T00:00:00Zhttp://www.dovepress.com/cross-reactivity-of-human-monoclonal-antibodies-generated-with-periphe-a14048https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Chonlatip Pipattanaboon,1,3,8,* Tadahiro Sasaki,2,8,* Mitsuhiro Nishimura,2,8 Chayanee Setthapramote,1,8 Pannamthip Pitaksajjakul,1,4,8 Pornsawan Leaungwutiwong,1,3,8 Kriengsak Limkittikul,5,8 Orapim Puiprom,6 Mikiko Sasayama,6 Panjaporn Chaichana,6 Tamaki Okabayashi,6 Takeshi Kurosu,2,8 Ken-ichiro Ono,7,8 Pongrama Ramasoota,1,4,8 Kazuyoshi Ikuta2,8 1Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; 2Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; 3Department of Microbiology and Immunology, 4Department of Social and Environmental Medicine, 5Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, 6Mahidol-Osaka Center for Infectious Diseases, Bangkok, Thailand; 7Medical and Biological Laboratories Corporation Ltd, Nagano, Japan; 8JST/JICA, Science and Technology Research Partnership for Sustainable Development, Tokyo, Japan *These authors made an equal contribution to this study Background: Hybridomas that produce human monoclonal antibodies (HuMAbs) against Dengue virus (DV) had been prepared previously using peripheral blood lymphocytes from patients with DV during the acute and convalescent phases of a secondary infection. Anti-DV envelope glycoprotein (E) 99 clones, anti-DV premembrane protein (prM) 8 clones, and anti-DV nonstructural protein 1 (NS1) 4 clones were derived from four acute-phase patients, and anti-DV E 2 clones, anti-DV prM 2 clones, and anti-DV NS1 8 clones were derived from five convalescent-phase patients. Methods and results: In the present study, we examined whether these clones cross-reacted with Japanese encephalitis virus (JEV), which belongs to the same virus family. Forty-six of the above-described 99 (46/99) anti-E, 0/8 anti-prM, and 2/4 anti-NS1 HuMAbs from acute-phase, and 0/2 anti-E, 0/2 anti-prM, and 5/8 anti-NS1 HuMAbs from convalescent-phase showed neutralizing activity against JEV. Thus, most of the anti-E and anti-NS1 (but not the anti-prM) antibodies cross-reacted with JEV and neutralized this virus. Interestingly, 3/46 anti-E HuMAbs derived from acute-phase patients and 3/5 anti-NS1 HuMAbs from convalescent-phase patients showed particularly high neutralizing activity against JEV. Consequently, the HuMAbs showing neutralization against JEV mostly consisted of two populations: one was HuMAbs recognizing DV E and showing neutralization activity against all four DV serotypes (complex-type) and the other was HuMAbs recognizing DV NS1 and showing subcomplex-type cross-reaction with DV. Conclusion: Anti-DV E from acute phase (46/99) and anti-DV NS1 (7/12) indicate neutralizing activity against JEV. In particular, three of 46 anti-DV E clones from acute phase and three of five anti-NS1 clones from convalescent phase showed strong neutralizing activity against JEV. Keywords: Dengue virus, Japanese encephalitis virus, viral neutralization, human monoclonal antibody, envelope, nonstructural protein 1Pipattanaboon CSasaki TNishimura MSetthapramote CPitaksajjakul PLeaungwutiwong PLimkittikul KPuiprom OSasayama MChaichana POkabayashi TKurosu TOno KRamasoota PIkuta KDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2013, Iss default, Pp 175-187 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Pipattanaboon C Sasaki T Nishimura M Setthapramote C Pitaksajjakul P Leaungwutiwong P Limkittikul K Puiprom O Sasayama M Chaichana P Okabayashi T Kurosu T Ono K Ramasoota P Ikuta K Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
description	Chonlatip Pipattanaboon,1,3,8,* Tadahiro Sasaki,2,8,* Mitsuhiro Nishimura,2,8 Chayanee Setthapramote,1,8 Pannamthip Pitaksajjakul,1,4,8 Pornsawan Leaungwutiwong,1,3,8 Kriengsak Limkittikul,5,8 Orapim Puiprom,6 Mikiko Sasayama,6 Panjaporn Chaichana,6 Tamaki Okabayashi,6 Takeshi Kurosu,2,8 Ken-ichiro Ono,7,8 Pongrama Ramasoota,1,4,8 Kazuyoshi Ikuta2,8 1Center of Excellence for Antibody Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; 2Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; 3Department of Microbiology and Immunology, 4Department of Social and Environmental Medicine, 5Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, 6Mahidol-Osaka Center for Infectious Diseases, Bangkok, Thailand; 7Medical and Biological Laboratories Corporation Ltd, Nagano, Japan; 8JST/JICA, Science and Technology Research Partnership for Sustainable Development, Tokyo, Japan *These authors made an equal contribution to this study Background: Hybridomas that produce human monoclonal antibodies (HuMAbs) against Dengue virus (DV) had been prepared previously using peripheral blood lymphocytes from patients with DV during the acute and convalescent phases of a secondary infection. Anti-DV envelope glycoprotein (E) 99 clones, anti-DV premembrane protein (prM) 8 clones, and anti-DV nonstructural protein 1 (NS1) 4 clones were derived from four acute-phase patients, and anti-DV E 2 clones, anti-DV prM 2 clones, and anti-DV NS1 8 clones were derived from five convalescent-phase patients. Methods and results: In the present study, we examined whether these clones cross-reacted with Japanese encephalitis virus (JEV), which belongs to the same virus family. Forty-six of the above-described 99 (46/99) anti-E, 0/8 anti-prM, and 2/4 anti-NS1 HuMAbs from acute-phase, and 0/2 anti-E, 0/2 anti-prM, and 5/8 anti-NS1 HuMAbs from convalescent-phase showed neutralizing activity against JEV. Thus, most of the anti-E and anti-NS1 (but not the anti-prM) antibodies cross-reacted with JEV and neutralized this virus. Interestingly, 3/46 anti-E HuMAbs derived from acute-phase patients and 3/5 anti-NS1 HuMAbs from convalescent-phase patients showed particularly high neutralizing activity against JEV. Consequently, the HuMAbs showing neutralization against JEV mostly consisted of two populations: one was HuMAbs recognizing DV E and showing neutralization activity against all four DV serotypes (complex-type) and the other was HuMAbs recognizing DV NS1 and showing subcomplex-type cross-reaction with DV. Conclusion: Anti-DV E from acute phase (46/99) and anti-DV NS1 (7/12) indicate neutralizing activity against JEV. In particular, three of 46 anti-DV E clones from acute phase and three of five anti-NS1 clones from convalescent phase showed strong neutralizing activity against JEV. Keywords: Dengue virus, Japanese encephalitis virus, viral neutralization, human monoclonal antibody, envelope, nonstructural protein 1
format	article
author	Pipattanaboon C Sasaki T Nishimura M Setthapramote C Pitaksajjakul P Leaungwutiwong P Limkittikul K Puiprom O Sasayama M Chaichana P Okabayashi T Kurosu T Ono K Ramasoota P Ikuta K
author_facet	Pipattanaboon C Sasaki T Nishimura M Setthapramote C Pitaksajjakul P Leaungwutiwong P Limkittikul K Puiprom O Sasayama M Chaichana P Okabayashi T Kurosu T Ono K Ramasoota P Ikuta K
author_sort	Pipattanaboon C
title	Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
title_short	Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
title_full	Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
title_fullStr	Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
title_full_unstemmed	Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
title_sort	cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with japanese encephalitis virus
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/f3dd272a402048f694762e6be757b112
work_keys_str_mv	AT pipattanaboonc crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT sasakit crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT nishimuram crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT setthapramotec crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT pitaksajjakulp crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT leaungwutiwongp crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT limkittikulk crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT puipromo crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT sasayamam crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT chaichanap crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT okabayashit crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT kurosut crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT onok crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT ramasootap crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus AT ikutak crossreactivityofhumanmonoclonalantibodiesgeneratedwithperipheralbloodlymphocytesfromdenguepatientswithjapaneseencephalitisvirus
_version_	1718402137911721984

Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus

Ejemplares similares